Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro Diagnostics

PUBLISHER: Visiongain | PRODUCT CODE: 1742447

Cover Image

PUBLISHER: Visiongain | PRODUCT CODE: 1742447

In Vitro Diagnostics Market Report 2025-2035

PUBLISHED:
PAGES: 356 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User) - 1 Year License
USD 6003
PDF (Team License - Up to 6 Users) - 1 Year License
USD 7107
PDF (Site License)
USD 8349
PDF (Enterprise License - Includes Free Datasets)
USD 10550.10

Add to Cart

Description

Table of Contents

List of Tables

The global In Vitro Diagnostics market is projected to grow at a CAGR of 5.1% by 2035.

The In Vitro Diagnostics Market Report 2025-2035 (Including Impact of U.S. Trade Tariffs): This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Technological Advancements Propelling Industry Growth

The in-vitro diagnostics (IVD) sector continues to experience significant growth, propelled by advancements in diagnostic technologies that enhance precision, portability, and affordability. A notable milestone was achieved in May 2025 when the U.S. Food and Drug Administration (FDA) approved the first blood test to aid in diagnosing Alzheimer's disease. Developed by Fujirebio Diagnostics, the Lumipulse G pTau217/CE<=-Amyloid 1-42 Plasma Ratio test measures specific biomarkers associated with Alzheimer's, offering a less invasive and more accessible alternative to traditional diagnostic methods like PET scans and spinal taps. This approval is expected to improve early detection and management of Alzheimer's disease, particularly benefiting the aging population .

In parallel, the oncology diagnostics landscape is being transformed by the adoption of blood-based tests for detecting minimal residual disease (MRD). Companies such as Guardant Health, Natera, and Exact Sciences are at the forefront of this revolution, utilising circulating tumour DNA to identify cancer recurrences much earlier than conventional imaging methods. These advancements enable more timely interventions and personalised treatment strategies, marking a significant shift in cancer care .

Segment Analysis

As of 2025, the reagents segment maintains its dominance in the IVD market, accounting for over 60% of the market share. This segment is projected to exhibit the highest compound annual growth rate (CAGR) through 2035, driven by continuous innovation and the development of novel diagnostic reagents and kits. A recent example includes the FDA's clearance of Werfen's Aptiva reagents for enhanced autoimmune diagnostics. These reagents offer improved specificity and efficiency in detecting autoimmune diseases, reflecting the industry's commitment to advancing diagnostic accuracy.

Furthermore, the demand for personalised medicine is fuelling the growth of companion diagnostics. In January 2025, Tempus AI, Inc. announced the national launch of its FDA-approved, next-generation sequencing (NGS)-based in vitro diagnostic device, xT CDx. This comprehensive test provides insights into a wide array of genetic alterations, aiding clinicians in selecting targeted therapies for cancer patients. The integration of such advanced diagnostics into clinical practice underscores the critical role of reagents in enabling precision medicine .

As the IVD industry continues to evolve, investments in research and development of innovative reagents and diagnostic tools remain pivotal. Companies focusing on these areas are well-positioned to lead in the competitive landscape, addressing emerging healthcare needs with cutting-edge solutions.

What would be the Impact of US Trade Tariffs on the Global In Vitro Diagnostics Market?

The influence of U.S. trade tariffs on the global In Vitro Diagnostics (IVD) market can be substantial, affecting cost structures and supply chain dynamics across various regions. A multitude of in vitro diagnostic (IVD) products, encompassing reagents, analysers, and components, are imported into the United States from nations such as China, Germany, and Japan. Tariffs on these imports can increase the cost of goods sold for U.S.-based diagnostics firms, potentially compressing profit margins or resulting in elevated prices for healthcare providers and patients.

The global ripple effect encompasses supply chain realignment, as companies may relocate sourcing or manufacturing to tariff-exempt nations, thereby augmenting operational complexity and expenses. Moreover, uncertainty surrounding tariffs may postpone investments in innovation or international collaborations, especially for small and medium-sized IVD companies dependent on global partnerships. In areas such as the EU and Asia-Pacific, this could create opportunities to enhance domestic production or secure a competitive advantage in exports to non-U.S. markets. In the long term, enduring tariffs may expedite localisation strategies, cultivate regional alliances, and transform the competitive dynamics of the global IVD industry.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the in vitro diagnostics market evolving?
  • What is driving and restraining the in vitro diagnostics market?
  • How will each in vitro diagnostics submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2035?
  • How will the market shares for each in vitro diagnostics submarket develop from 2025 to 2035?
  • What will be the main driver for the overall market from 2025 to 2035?
  • Will leading in vitro diagnostics markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2035 and which geographical region will lead the market in 2035?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the in vitro diagnostics projects for these leading companies?
  • How will the industry evolve during the period between 2025 and 2035?
  • What are the implications of
  • in vitro diagnostics projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the in vitro diagnostics market?
  • Where is the in vitro diagnostics market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the in vitro diagnostics market today, and over the next 10 years:

  • Our 356-page report provides 125 tables, 212 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
  • Forecasts to 2035 and other analyses reveal commercial prospects
  • In addition to revenue forecasting to 2035, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter,Aos Five Forces Analysis, PEST Analysis and recent developments.

Segments Covered in the Report

  • Product
  • Instruments
  • Reagents & Kits
  • Test
  • Clinical Chemistry
  • Immunoassay/Immunochemistry
  • Molecular Diagnostics
  • Hematology
  • Urinalysis
  • Others
  • Application
  • Cardiology
  • Diabetes
  • Oncology
  • Infectious Diseases
  • Nephrology
  • Autoimmune Diseases
  • Drug Testing/Pharmacogenomics
  • Others
  • End-users
  • Academic & Research Institutes
  • Diagnostic Laboratories
  • Hospitals
  • Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 20 leading national markets:

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • MEA
  • GCC
  • South Africa
  • Rest of MEA

The report also includes profiles for some of the leading companies in the In Vitro Diagnostics Market, 2025 to 2035, with a focus on this segment of these companies'operations.

  • Leading companies and the potential for market growth
  • QIAGEN
  • BD
  • bioMerieux
  • F. Hoffmann-La Roche, Ltd.
  • Quidel
  • Ortho Corporation
  • Abbott
  • Agilent Technologies, Inc.
  • Thermofisher Scientific, Inc.
  • Siemens Healthineers AG
  • Bio-Rad Laboratories, Inc.
  • Danaher
  • Sysmex Corporation
  • Charles River Laboratories
  • Quest Diagnostics Incorporated
  • Illumina, Inc.
  • Hologic
  • Revvity
  • Exact Sciences

Overall world revenue for In Vitro Diagnostics Market, 2025 to 2035 in terms of value the market will surpass US$95 billion in 2025, our work calculates. We predict strong revenue growth through to 2035. Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

  • How will the In Vitro Diagnostics Market, 2025 to 2035 report help you?
  • In summary, our 350+ page report provides you with the following knowledge:
  • Revenue forecasts to 2035 for In Vitro Diagnostics Market 2025 to 2035, with forecasts for Product, Test, Application, and End-users, each forecast at a global and regional level - discover the industry,Aos prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2035 for five regional and 20 key national markets - See forecasts for the In Vitro Diagnostics Market, 2025 to 2035 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 19 of the major companies involved in the In Vitro Diagnostics Market, 2025 to 2035.
  • Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
  • Information found nowhere else
  • With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain,Aos study is for everybody needing commercial analyses for the In Vitro Diagnostics Market 2025 to 2035, market-leading companies. You will find data, trends and predictions.
Show more
Product Code: PHA1360

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to In Vitro Diagnostics Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report Include:
  • 1.6 Who is This Report For?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
  • 3.3 Impact Analysis
    • 3.3.1 Market Driving Factors
      • 3.3.1.1 Introduction of Technologically Advanced Products
      • 3.3.1.2 Rise in Geriatric Population
      • 3.3.1.3 Increasing Demand of PoC Testing
    • 3.3.2 Market Restraining Factors
      • 3.3.2.1 High Cost of Diagnostic Equipment
      • 3.3.2.2 Stringent Regulatory Requirements in IVD
    • 3.3.3 Market Opportunities
      • 3.3.3.1 Improvement in Immunoassay Diagnostic Technologies
      • 3.3.3.2 Expansion in Emerging Markets
      • 3.3.3.3 Growth of Home-based and Point-of-Care Testing
  • 3.4 U.S. Tariffs: What,Aos the Impact on Global In Vitro Diagnostics Market?
    • 3.4.1 Overview
    • 3.4.2 V-Shaped Recovery Scenario
    • 3.4.3 Why V-Shaped Recovery?
      • 3.4.3.1 Impact from Tariffs
      • 3.4.3.2 Market Dynamics and Demand Recovery
      • 3.4.3.3 Policy and Funding Support
      • 3.4.3.4 Timeframe for Recovery
    • 3.4.4 U-Shaped Recovery Scenario
      • 3.4.4.1 Why U-Shaped Recovery?
      • 3.4.4.2 Impact from Tariffs
      • 3.4.4.3 Market Dynamics and Demand Recovery
      • 3.4.4.4 Policy and Funding Support
      • 3.4.4.5 Timeframe for Recovery
    • 3.4.5 L Shaped Recovery Scenario
      • 3.4.5.1 Why L-Shaped Recovery?
      • 3.4.5.2 Impact from Tariffs
      • 3.4.5.3 Market Dynamics and Demand Recovery
      • 3.4.5.4 Policy and Funding Support
      • 3.4.5.5 Timeframe for Recovery
    • 3.4.6 What Strategic Considerations Should Clients Factor into Their Near-term (2025-2030) and Long-term (2025-2035) Planning?
    • 3.4.7 Impact of U.S. and China Trade War on In Vitro Diagnostics Market
    • 3.4.8 How Might the Most Impacted Countries Experience Positive and Negative Effects Resulting from These Policy Changes?
    • 3.4.9 Sensitivity Mapping for the Trade Tariff Impact
  • 3.5 Porter,Aos Five Forces Analysis
    • 3.5.1 Bargaining Power of Suppliers
    • 3.5.2 Bargaining Power of Buyers
    • 3.5.3 Competitive Rivalry
    • 3.5.4 Threat of Substitutes
    • 3.5.5 Threat of New Entrants
  • 3.6 PEST Analysis
    • 3.6.1 Political
    • 3.6.2 Economical
    • 3.6.3 Social
    • 3.6.4 Technological
  • 3.7 Impact of Trump Tariffs on In Vitro Diagnostics Market
    • 3.7.1 Trade Barriers and Supply Chain Disruption
    • 3.7.2 Cost Implications for U.S. and Global Manufacturers
    • 3.7.3 Policy Uncertainty and Investment Hesitation

4 In Vitro Diagnostics Market Analysis by Product

  • 4.1 Key Findings
  • 4.2 Product Segment: Market Attractiveness Index
  • 4.3 In Vitro Diagnostics Market Size Estimation and Forecast by Product
  • 4.4 Instruments
    • 4.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 4.4.2 Market Share by Region, 2025 & 2035 (%)
  • 4.5 Reagents & Kits
    • 4.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 4.5.2 Market Share by Region, 2025 & 2035 (%)

5 In Vitro Diagnostics Market Analysis by Test

  • 5.1 Key Findings
  • 5.2 Test Segment: Market Attractiveness Index
  • 5.3 In Vitro Diagnostics Market Size Estimation and Forecast by Test
  • 5.4 Clinical Chemistry
    • 5.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 5.4.2 Market Share by Region, 2025 & 2035 (%)
  • 5.5 Immunoassay/Immunochemistry
    • 5.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 5.5.2 Market Share by Region, 2025 & 2035 (%)
  • 5.6 Molecular Diagnostics
    • 5.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 5.6.2 Market Share by Region, 2025 & 2035 (%)
  • 5.7 Haematology
    • 5.7.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 5.7.2 Market Share by Region, 2025 & 2035 (%)
  • 5.8 Urinalysis
    • 5.8.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 5.8.2 Market Share by Region, 2025 & 2035 (%)
  • 5.9 Others
    • 5.9.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 5.9.2 Market Share by Region, 2025 & 2035 (%)

6 In Vitro Diagnostics Market Analysis by Application

  • 6.1 Key Findings
  • 6.2 Application Segment: Market Attractiveness Index
  • 6.3 In Vitro Diagnostics Market Size Estimation and Forecast by Application
  • 6.4 Cardiology
    • 6.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 6.4.2 Market Share by Region, 2025 & 2035 (%)
  • 6.5 Diabetes
    • 6.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 6.5.2 Market Share by Region, 2025 & 2035 (%)
  • 6.6 Oncology
    • 6.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 6.6.2 Market Share by Region, 2025 & 2035 (%)
  • 6.7 Infectious Diseases
    • 6.7.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 6.7.2 Market Share by Region, 2025 & 2035 (%)
  • 6.8 Maternal Disorders
    • 6.8.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 6.8.2 Market Share by Region, 2025 & 2035 (%)
  • 6.9 Mobility Disorders
    • 6.9.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 6.9.2 Market Share by Region, 2025 & 2035 (%)
  • 6.10 Autoimmune Diseases
    • 6.10.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 6.10.2 Market Share by Region, 2025 & 2035 (%)
  • 6.11 Drug Testing/Pharmacogenomics
    • 6.11.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 6.11.2 Market Share by Region, 2025 & 2035 (%)
  • 6.12 Others
    • 6.12.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 6.12.2 Market Share by Region, 2025 & 2035 (%)

7 In Vitro Diagnostics Market Analysis by End-users

  • 7.1 Key Findings
  • 7.2 End-users Segment: Market Attractiveness Index
  • 7.3 In Vitro Diagnostics Market Size Estimation and Forecast by End-users
  • 7.4 Academic & Research Institutes
    • 7.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 7.4.2 Market Share by Region, 2025 & 2035 (%)
  • 7.5 Diagnostic Laboratories
    • 7.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 7.5.2 Market Share by Region, 2025 & 2035 (%)
  • 7.6 Hospitals
    • 7.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 7.6.2 Market Share by Region, 2025 & 2035 (%)
  • 7.7 Others
    • 7.7.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 7.7.2 Market Share by Region, 2025 & 2035 (%)

8 In Vitro Diagnostics Market Analysis by Region

  • 8.1 Key Findings
  • 8.2 Regional Market Size Estimation and Forecast

9 North America In Vitro Diagnostics Market Analysis

  • 9.1 Key Findings
  • 9.2 North America In Vitro Diagnostics Market Attractiveness Index
  • 9.3 North America In Vitro Diagnostics Market by Country, 2025, 2030 & 2035 (US$ Billion)
  • 9.4 North America In Vitro Diagnostics Market Size Estimation and Forecast by Country
  • 9.5 North America In Vitro Diagnostics Market Size Estimation and Forecast by Product
  • 9.6 North America In Vitro Diagnostics Market Size Estimation and Forecast by Test
  • 9.7 North America In Vitro Diagnostics Market Size Estimation and Forecast by Application
  • 9.8 North America In Vitro Diagnostics Market Size Estimation and Forecast by End-users
  • 9.9 U.S. In Vitro Diagnostics Market Analysis
  • 9.10 Canada In Vitro Diagnostics Market Analysis

10 Europe In Vitro Diagnostics Market Analysis

  • 10.1 Key Findings
  • 10.2 Europe In Vitro Diagnostics Market Attractiveness Index
  • 10.3 Europe In Vitro Diagnostics Market by Country, 2025, 2030 & 2035 (US$ Billion)
  • 10.4 Europe In Vitro Diagnostics Market Size Estimation and Forecast by Country
  • 10.5 Europe In Vitro Diagnostics Market Size Estimation and Forecast by Product
  • 10.6 Europe In Vitro Diagnostics Market Size Estimation and Forecast by Test
  • 10.7 Europe In Vitro Diagnostics Market Size Estimation and Forecast by Application
  • 10.8 Europe In Vitro Diagnostics Market Size Estimation and Forecast by End-users
  • 10.9 Germany In Vitro Diagnostics Market Analysis
  • 10.10 UK In Vitro Diagnostics Market Analysis
  • 10.11 France In Vitro Diagnostics Market Analysis
  • 10.12 Italy In Vitro Diagnostics Market Analysis
  • 10.13 Spain In Vitro Diagnostics Market Analysis
  • 10.14 Rest of Europe In Vitro Diagnostics Market Analysis

11 Asia Pacific In Vitro Diagnostics Market Analysis

  • 11.1 Key Findings
  • 11.2 Asia Pacific In Vitro Diagnostics Market Attractiveness Index
  • 11.3 Asia Pacific In Vitro Diagnostics Market by Country, 2025, 2030 & 2035 (US$ Billion)
  • 11.4 Asia Pacific In Vitro Diagnostics Market Size Estimation and Forecast by Country
  • 11.5 Asia Pacific In Vitro Diagnostics Market Size Estimation and Forecast by Product
  • 11.6 Asia Pacific In Vitro Diagnostics Market Size Estimation and Forecast by Test
  • 11.7 Asia Pacific In Vitro Diagnostics Market Size Estimation and Forecast by Application
  • 11.8 Asia Pacific In Vitro Diagnostics Market Size Estimation and Forecast by End-users
  • 11.9 Japan In Vitro Diagnostics Market Analysis
  • 11.10 China In Vitro Diagnostics Market Analysis
  • 11.11 India In Vitro Diagnostics Market Analysis
  • 11.12 Australia In Vitro Diagnostics Market Analysis
  • 11.13 Rest of Asia Pacific In Vitro Diagnostics Market Analysis

12 Latin America In Vitro Diagnostics Market Analysis

  • 12.1 Key Findings
  • 12.2 Latin America In Vitro Diagnostics Market Attractiveness Index
  • 12.3 Latin America In Vitro Diagnostics Market by Country, 2025, 2030 & 2035 (US$ Billion)
  • 12.4 Latin America In Vitro Diagnostics Market Size Estimation and Forecast by Country
  • 12.5 Latin America In Vitro Diagnostics Market Size Estimation and Forecast by Product
  • 12.6 Latin America In Vitro Diagnostics Market Size Estimation and Forecast by Test
  • 12.7 Latin America In Vitro Diagnostics Market Size Estimation and Forecast by Application
  • 12.8 Latin America In Vitro Diagnostics Market Size Estimation and Forecast by End-users
  • 12.9 Brazil In Vitro Diagnostics Market Analysis
  • 12.10 Mexico In Vitro Diagnostics Market Analysis
  • 12.11 Rest of Latin America In Vitro Diagnostics Market Analysis

13 MEA In Vitro Diagnostics Market Analysis

  • 13.1 Key Findings
  • 13.2 MEA In Vitro Diagnostics Market Attractiveness Index
  • 13.3 MEA In Vitro Diagnostics Market by Country, 2025, 2030 & 2035 (US$ Billion)
  • 13.4 MEA In Vitro Diagnostics Market Size Estimation and Forecast by Country
  • 13.5 MEA In Vitro Diagnostics Market Size Estimation and Forecast by Product
  • 13.6 MEA In Vitro Diagnostics Market Size Estimation and Forecast by Test
  • 13.7 MEA In Vitro Diagnostics Market Size Estimation and Forecast by Application
  • 13.8 MEA In Vitro Diagnostics Market Size Estimation and Forecast by End-users
  • 13.9 GCC In Vitro Diagnostics Market Analysis
  • 13.10 South Africa In Vitro Diagnostics Market Analysis
  • 13.11 Rest of MEA In Vitro Diagnostics Market Analysis

14 Company Profiles

  • 14.1 QIAGEN
    • 14.1.1 Company Snapshot
    • 14.1.2 Company Overview
    • 14.1.3 Financial Analysis
      • 14.1.3.1 Net Revenue, 2020-2024
      • 14.1.3.2 R&D, 2020-2024
      • 14.1.3.3 Regional Market Shares, 2024
      • 14.1.3.4 Business Segment Market Shares, 2024
    • 14.1.4 Product Benchmarking
    • 14.1.5 SWOT Analysis
    • 14.1.6 Strategic Outlook
  • 14.2 BD
    • 14.2.1 Company Snapshot
    • 14.2.2 Company Overview
    • 14.2.3 Financial Analysis
      • 14.2.3.1 Net Revenue, 2020-2024
      • 14.2.3.2 R&D, 2020-2024
      • 14.2.3.3 Business Segment Market Shares, 2024
    • 14.2.4 Product Benchmarking
    • 14.2.5 SWOT Analysis
  • 14.3 bioMerieux
    • 14.3.1 Company Snapshot
    • 14.3.2 Company Overview
    • 14.3.3 Financial Analysis
      • 14.3.3.1 Net Revenue, 2020-2024
      • 14.3.3.2 R&D, 2020-2024
      • 14.3.3.3 Regional Market Shares, 2024
    • 14.3.4 Product Benchmarking
    • 14.3.5 SWOT Analysis
    • 14.3.6 Strategic Outlook
  • 14.4 F. Hoffmann-La Roche, Ltd.
    • 14.4.1 Company Snapshot
    • 14.4.2 Company Overview
    • 14.4.3 Financial Analysis
      • 14.4.3.1 Net Revenue, 2020-2024
      • 14.4.3.2 R&D, 2020-2024
      • 14.4.3.3 Business Segment Market Shares, 2024
    • 14.4.4 Product Benchmarking
    • 14.4.5 SWOT Analysis
    • 14.4.6 Strategic Outlook
  • 14.5 QuidelOrtho Corporation
    • 14.5.1 Company Snapshot
    • 14.5.2 Company Overview
    • 14.5.3 Financial Analysis
      • 14.5.3.1 Net Revenue, 2020-2024
      • 14.5.3.2 R&D, 2020-2024
      • 14.5.3.3 Regional Market Shares, 2024
      • 14.5.3.4 Business Segment Market Shares, 2024
    • 14.5.4 Product Benchmarking
    • 14.5.5 SWOT Analysis
    • 14.5.6 Strategic Outlook
  • 14.6 Abbott
    • 14.6.1 Company Snapshot
    • 14.6.2 Company Overview
    • 14.6.3 Financial Analysis
      • 14.6.3.1 Net Revenue, 2020-2024
      • 14.6.3.2 R&D, 2020-2024
      • 14.6.3.3 Regional Market Shares, 2024
      • 14.6.3.4 Business Segment Market Shares, 2024
    • 14.6.4 Product Benchmarking
  • 14.7 Agilent Technologies, Inc.
    • 14.7.1 Company Snapshot
    • 14.7.2 Company Overview
    • 14.7.3 Financial Analysis
      • 14.7.3.1 Net Revenue, 2020-2024
      • 14.7.3.2 R&D, 2020-2024
      • 14.7.3.3 Regional Market Shares, 2024
      • 14.7.3.4 Business Segment Market Shares, 2024
    • 14.7.4 Product Benchmarking
    • 14.7.5 Strategic Outlook
  • 14.8 Thermofisher Scientific, Inc.
    • 14.8.1 Company Snapshot
    • 14.8.2 Company Overview
    • 14.8.3 Financial Analysis
      • 14.8.3.1 Net Revenue, 2020-2024
      • 14.8.3.2 R&D, 2020-2024
      • 14.8.3.3 Regional Market Shares, 2024
      • 14.8.3.4 Business Segment Market Shares, 2024
    • 14.8.4 Product Benchmarking
    • 14.8.5 Strategic Outlook
  • 14.9 Siemens Healthineers AG
    • 14.9.1 Company Snapshot
    • 14.9.2 Company Overview
    • 14.9.3 Financial Analysis
      • 14.9.3.1 Net Revenue, 2020-2024
      • 14.9.3.2 Regional Market Shares, 2024
      • 14.9.3.3 Business Segment Market Shares, 2024
    • 14.9.4 Product Benchmarking
    • 14.9.5 Strategic Outlook
  • 14.10 Bio-Rad Laboratories, Inc.
    • 14.10.1 Company Snapshot
    • 14.10.2 Company Overview
    • 14.10.3 Financial Analysis
      • 14.10.3.1 Net Revenue, 2020-2024
      • 14.10.3.2 Regional Market Shares, 2024
      • 14.10.3.3 Business Segment Market Shares, 2024
    • 14.10.4 Product Benchmarking
    • 14.10.5 Strategic Outlook
  • 14.11 Danaher
    • 14.11.1 Company Snapshot
    • 14.11.2 Company Overview
    • 14.11.3 Financial Analysis
      • 14.11.3.1 Net Revenue, 2020-2024
      • 14.11.3.2 R&D, 2020-2024
      • 14.11.3.3 Regional Market Shares, 2024
      • 14.11.3.4 Business Segment Market Shares, 2024
    • 14.11.4 Product Benchmarking
    • 14.11.5 Strategic Outlook
  • 14.12 Sysmex Corporation
    • 14.12.1 Company Snapshot
    • 14.12.2 Company Overview
    • 14.12.3 Financial Analysis
      • 14.12.3.1 Net Revenue, 2020-2024
      • 14.12.3.2 R&D, 2020-2024
    • 14.12.4 Product Benchmarking
    • 14.12.5 Strategic Outlook
  • 14.13 Charles River Laboratories
    • 14.13.1 Company Snapshot
    • 14.13.2 Company Overview
    • 14.13.3 Financial Analysis
      • 14.13.3.1 Net Revenue, 2020-2024
      • 14.13.3.2 Regional Market Shares, 2024
      • 14.13.3.3 Business Segment Market Shares, 2024
    • 14.13.4 Services Benchmarking
  • 14.14 Quest Diagnostics Incorporated
    • 14.14.1 Company Snapshot
    • 14.14.2 Company Overview
    • 14.14.3 Financial Analysis
      • 14.14.3.1 Net Revenue, 2020-2024
      • 14.14.3.2 Business Segment Market Shares, 2024
    • 14.14.4 Product Benchmarking
    • 14.14.5 Strategic Outlook
  • 14.15 Illumina, Inc.
    • 14.15.1 Company Snapshot
    • 14.15.2 Company Overview
    • 14.15.3 Financial Analysis
      • 14.15.3.1 Net Revenue, 2020-2024
      • 14.15.3.2 R&D, 2020-2024
      • 14.15.3.3 Regional Market Shares, 2024
      • 14.15.3.4 Business Segment Market Shares, 2024
    • 14.15.4 Product Benchmarking
    • 14.15.5 Strategic Outlook
  • 14.16 Hologic
    • 14.16.1 Company Snapshot
    • 14.16.2 Company Overview
    • 14.16.3 Financial Analysis
      • 14.16.3.1 Net Revenue, 2020-2024
      • 14.16.3.2 R&D, 2020-2024
      • 14.16.3.3 Regional Market Shares, 2024
      • 14.16.3.4 Business Segment Market Shares, 2024
    • 14.16.4 Product Benchmarking
    • 14.16.5 Strategic Outlook
  • 14.17 Exact Sciences
    • 14.17.1 Company Snapshot
    • 14.17.2 Company Overview
    • 14.17.3 Financial Analysis
      • 14.17.3.1 Net Revenue, 2020-2024
      • 14.17.3.2 R&D, 2020-2024
      • 14.17.3.3 Regional Market Shares, 2024
    • 14.17.4 Product Benchmarking
  • 14.18 Revvity
    • 14.18.1 Company Snapshot
    • 14.18.2 Company Overview
    • 14.18.3 Financial Analysis
      • 14.18.3.1 Net Revenue, 2020-2024
      • 14.18.3.2 R&D, 2020-2024
    • 14.18.4 Product Benchmarking
    • 14.18.5 Strategic Outlook

15 Conclusion and Recommendations

  • 15.1 Concluding Remarks from Visiongain
  • 15.2 Recommendations for Market Players
Show more
Product Code: PHA1360

List of Tables

  • Table 1 In Vitro Diagnostics Market Snapshot, 2025 & 2035 (US$ Billion, CAGR %)
  • Table 2 In Vitro Diagnostics Market: International Trade Tariff Impact Recovery Scenarios Snapshot
  • Table 3 In Vitro Diagnostics Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%): "V" Shaped Recovery
  • Table 4 In Vitro Diagnostics Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%): "U" Shaped Recovery
  • Table 5 In Vitro Diagnostics Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%): "L" Shaped Recovery
  • Table 6 In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 7 Instruments Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 8 Reagents & Kits Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 9 In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 10 Clinical Chemistry Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 11 Immunoassay/Immunochemistry Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 12 Molecular Diagnostics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 13 Haematology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 14 Urinalysis Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 15 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 16 In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 17 Cardiology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 18 Diabetes Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 19 Oncology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 20 Infectious Diseases Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 21 Maternal Disorders Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 22 Mobility Disorders Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 23 Autoimmune Diseases Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 24 Drug Testing/Pharmacogenomics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 25 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 26 Diagnostic Segment Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 27 Academic & Research Institutes Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 28 Diagnostic Laboratories Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 29 Hospitals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 30 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 31 In Vitro Diagnostics Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 32 North America In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 33 North America In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 34 North America In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 35 North America In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 36 North America In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 37 U.S. In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 38 Canada In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 39 Europe In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 40 Europe In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 41 Europe In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 42 Europe In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 43 Europe In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 44 Germany In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 45 UK In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 46 France In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 47 Italy In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 48 Spain In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 49 Rest of Europe In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 50 Asia Pacific In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 51 Asia Pacific In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 52 Asia Pacific In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 53 Asia Pacific In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 54 Asia Pacific In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 55 Japan In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 56 China In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 57 India In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 58 Australia In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 59 Rest of Asia Pacific In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 60 Latin America In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 61 Latin America In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 62 Latin America In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 63 Latin America In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 64 Latin America In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 65 Brazil In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 66 Mexico In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 67 Rest of Latin America In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 68 MEA In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 69 MEA In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 70 MEA In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 71 MEA In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 72 MEA In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 73 GCC Home Healthcare Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 74 South Africa Home Healthcare Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 75 Rest of MEA Home Healthcare Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 76 QIAGEN: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 77 QIAGEN: Product Benchmarking
  • Table 78 QIAGEN: SWOT Analysis
  • Table 79 QIAGEN: Strategic Outlook
  • Table 80 BD: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 81 BD: Product Benchmarking
  • Table 82 BD: SWOT Analysis
  • Table 83 bioMerieux: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 84 bioMerieux: Product Benchmarking
  • Table 85 bioMerieux: SWOT Analysis
  • Table 86 bioMerieux: Strategic Outlook
  • Table 87 F. Hoffmann-La Roche, Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 88 F. Hoffmann-La Roche, Ltd.: Product Benchmarking
  • Table 89 F. Hoffmann-La Roche, Ltd.: SWOT Analysis
  • Table 90 F. Hoffmann-La Roche, Ltd.: Strategic Outlook
  • Table 91 QuidelOrtho Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 92 QuidelOrtho Corporation: Product Benchmarking
  • Table 93 QuidelOrtho Corporation: SWOT Analysis
  • Table 94 QuidelOrtho Corporation: Strategic Outlook
  • Table 95 Abbott: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 96 Abbott: Product Benchmarking
  • Table 97 Agilent Technologies, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 98 Agilent Technologies, Inc.: Product Benchmarking
  • Table 99 Agilent Technologies, Inc.: Strategic Outlook
  • Table 100 Thermofisher Scientific, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 101 Thermofisher Scientific, Inc.: Product Benchmarking
  • Table 102 Thermofisher Scientific, Inc.: Strategic Outlook
  • Table 103 Siemens Healthineers AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 104 Siemens Healthineers AG: Product Benchmarking
  • Table 105 Siemens Healthineers AG: Strategic Outlook
  • Table 106 Bio-Rad Laboratories, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 107 Bio-Rad Laboratories, Inc.: Product Benchmarking
  • Table 108 Bio-Rad Laboratories, Inc.: Strategic Outlook
  • Table 109 Danaher: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 110 Danaher: Product Benchmarking
  • Table 111 Danaher: Strategic Outlook
  • Table 112 Sysmex Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 113 Sysmex Corporation: Product Benchmarking
  • Table 114 Sysmex Corporation: Strategic Outlook
  • Table 115 Charles River Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 116 Charles River Laboratories: Services Benchmarking
  • Table 117 Quest Diagnostics Incorporated: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 118 Quest Diagnostics Incorporated: Product Benchmarking
  • Table 119 Quest Diagnostics Incorporated: Strategic Outlook
  • Table 120 Illumina, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 121 Illumina, Inc.: Product Benchmarking
  • Table 122 Illumina, Inc.: Strategic Outlook
  • Table 123 Hologic: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 124 Hologic: Product Benchmarking
  • Table 125 Hologic: Strategic Outlook
  • Table 126 Exact Sciences: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 127 Exact Sciences: Product Benchmarking
  • Table 128 Revvity: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 129 Revvity: Product Benchmarking
  • Table 130 Revvity: Strategic Outlook

List of Figures

  • Figure 1 In Vitro Diagnostics Market Segmentation
  • Figure 2 In Vitro Diagnostics Market by Product: Market Attractiveness Index
  • Figure 3 In Vitro Diagnostics Market by Test: Market Attractiveness Index
  • Figure 4 In Vitro Diagnostics Market by Application: Market Attractiveness Index
  • Figure 5 In Vitro Diagnostics Market by End-users: Market Attractiveness Index
  • Figure 6 In Vitro Diagnostics Market Attractiveness Index by Region
  • Figure 7 In Vitro Diagnostics Market: Market Dynamics
  • Figure 8 In Vitro Diagnostics Market: Impact Analysis
  • Figure 9 In Vitro Diagnostics Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: V-Shaped Recovery Scenario
  • Figure 10 In Vitro Diagnostics Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: U-Shaped Recovery Scenario
  • Figure 11 In Vitro Diagnostics Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: L-Shaped Recovery Scenario
  • Figure 12 Short Term & Long Term Planning
  • Figure 13 Impact of U.S. and China Trade War
  • Figure 14 Most Impacted Countries
  • Figure 15 Sensitivity Mapping for Tariff Impact
  • Figure 16 In Vitro Diagnostics Market: Porter,Aos Five Forces Analysis
  • Figure 17 In Vitro Diagnostics Market: PEST Analysis
  • Figure 18 In Vitro Diagnostics Market Attractiveness Index by Product
  • Figure 19 In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
  • Figure 20 In Vitro Diagnostics Market Share Forecast by Product, 2025, 2030, 2035 (%)
  • Figure 21 Instruments Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 22 Instruments Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 23 Reagents & Kits Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 24 Reagents & Kits Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 25 In Vitro Diagnostics Market Attractiveness Index by Product
  • Figure 26 In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR %)
  • Figure 27 In Vitro Diagnostics Market Share Forecast by Test, 2025, 2030, 2035 (%)
  • Figure 28 Clinical Chemistry Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 29 Clinical Chemistry Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 30 Immunoassay/Immunochemistry Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 31 Immunoassay/Immunochemistry Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 32 Molecular Diagnostics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 33 Molecular Diagnostics Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 34 Haematology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 35 Haematology Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 36 Urinalysis Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 37 Urinalysis Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 38 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 39 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 40 In Vitro Diagnostics Market Attractiveness Index by Application
  • Figure 41 In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
  • Figure 42 In Vitro Diagnostics Market Share Forecast by Application, 2025, 2030, 2035 (%)
  • Figure 43 Cardiology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 44 Cardiology Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 45 Diabetes Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 46 Diabetes Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 47 Oncology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 48 Oncology Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 49 Infectious Diseases Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 50 Infectious Diseases Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 51 Maternal Disorders Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 52 Maternal Disorders Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 53 Mobility Disorders Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 54 Mobility Disorders Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 55 Autoimmune Diseases Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 56 Autoimmune Diseases Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 57 Drug Testing/Pharmacogenomics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 58 Drug Testing/Pharmacogenomics Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 59 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 60 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 61 In Vitro Diagnostics Market Attractiveness Index by End-users
  • Figure 62 In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
  • Figure 63 In Vitro Diagnostics Market Share Forecast by End-users, 2025, 2030, 2035 (%)
  • Figure 64 Academic & Research Institutes Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 65 Academic & Research Institutes Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 66 Diagnostic Laboratories Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 67 Diagnostic Laboratories Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 68 Hospitals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 69 Hospitals Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 70 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 71 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 72 In Vitro Diagnostics Market Forecast by Region 2025, 2030, 2035 (Revenue, CAGR%)
  • Figure 73 In Vitro Diagnostics Market Share Forecast by Region 2025, 2030, 2035 (%)
  • Figure 74 In Vitro Diagnostics Market by Region, 2025-2035 (US$ Mn)
  • Figure 75 North America In Vitro Diagnostics Market Attractiveness Index
  • Figure 76 North America In Vitro Diagnostics Market by Region, 2025, 2030 & 2035 (US$ Billion)
  • Figure 77 North America In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
  • Figure 78 North America In Vitro Diagnostics Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 79 North America In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
  • Figure 80 North America In Vitro Diagnostics Market Share Forecast by Product, 2025 & 2035 (%)
  • Figure 81 North America In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR %)
  • Figure 82 North America In Vitro Diagnostics Market Share Forecast by Test, 2025 & 2035 (%)
  • Figure 83 North America In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
  • Figure 84 North America In Vitro Diagnostics Market Share Forecast by Application, 2025 & 2035 (%)
  • Figure 85 North America In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
  • Figure 86 North America In Vitro Diagnostics Market Share Forecast by End-users, 2025 & 2035 (%)
  • Figure 87 U.S. In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 88 Canada In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 89 Europe In Vitro Diagnostics Market Attractiveness Index
  • Figure 90 Europe In Vitro Diagnostics Market by Region, 2025, 2030 & 2035 (US$ Billion)
  • Figure 91 Europe In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
  • Figure 92 Europe In Vitro Diagnostics Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 93 Europe In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
  • Figure 94 Europe In Vitro Diagnostics Market Share Forecast by Product, 2025 & 2035 (%)
  • Figure 95 Europe In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR %)
  • Figure 96 Europe In Vitro Diagnostics Market Share Forecast by Test, 2025 & 2035 (%)
  • Figure 97 Europe In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
  • Figure 98 Europe In Vitro Diagnostics Market Share Forecast by Application, 2025 & 2035 (%)
  • Figure 99 Europe In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
  • Figure 100 Europe In Vitro Diagnostics Market Share Forecast by End-users, 2025 & 2035 (%)
  • Figure 101 Germany In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 102 UK In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 103 France In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 104 Italy In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 105 Spain In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 106 Rest of Europe In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 107 Asia Pacific In Vitro Diagnostics Market Attractiveness Index
  • Figure 108 Asia Pacific In Vitro Diagnostics Market by Region, 2025, 2030 & 2035 (US$ Billion)
  • Figure 109 Asia Pacific In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
  • Figure 110 Asia Pacific In Vitro Diagnostics Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 111 Asia Pacific In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
  • Figure 112 Asia Pacific In Vitro Diagnostics Market Share Forecast by Product, 2025 & 2035 (%)
  • Figure 113 Asia Pacific In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR %)
  • Figure 114 Asia Pacific In Vitro Diagnostics Market Share Forecast by Test, 2025 & 2035 (%)
  • Figure 115 Asia Pacific In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
  • Figure 116 Asia Pacific In Vitro Diagnostics Market Share Forecast by Application, 2025 & 2035 (%)
  • Figure 117 Asia Pacific In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
  • Figure 118 Asia Pacific In Vitro Diagnostics Market Share Forecast by End-users, 2025 & 2035 (%)
  • Figure 119 Japan In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 120 China In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 121 India In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 122 Australia In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 123 Rest of Asia Pacific In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 124 Latin America In Vitro Diagnostics Market Attractiveness Index
  • Figure 125 Latin America In Vitro Diagnostics Market by Region, 2025, 2030 & 2035 (US$ Billion)
  • Figure 126 Latin America In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
  • Figure 127 Latin America In Vitro Diagnostics Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 128 Latin America In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
  • Figure 129 Latin America In Vitro Diagnostics Market Share Forecast by Product, 2025 & 2035 (%)
  • Figure 130 Latin America In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR %)
  • Figure 131 Latin America In Vitro Diagnostics Market Share Forecast by Test, 2025 & 2035 (%)
  • Figure 132 Latin America In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
  • Figure 133 Latin America In Vitro Diagnostics Market Share Forecast by Application, 2025 & 2035 (%)
  • Figure 134 Latin America In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
  • Figure 135 Latin America In Vitro Diagnostics Market Share Forecast by End-users, 2025 & 2035 (%)
  • Figure 136 Brazil In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 137 Mexico In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 138 Rest of Latin America In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 139 MEA In Vitro Diagnostics Market Attractiveness Index
  • Figure 140 MEA In Vitro Diagnostics Market by Region, 2025, 2030 & 2035 (US$ Billion)
  • Figure 141 MEA In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
  • Figure 142 MEA In Vitro Diagnostics Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 143 MEA In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
  • Figure 144 MEA In Vitro Diagnostics Market Share Forecast by Product, 2025 & 2035 (%)
  • Figure 145 MEA In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR %)
  • Figure 146 MEA In Vitro Diagnostics Market Share Forecast by Test, 2025 & 2035 (%)
  • Figure 147 MEA In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
  • Figure 148 MEA In Vitro Diagnostics Market Share Forecast by Application, 2025 & 2035 (%)
  • Figure 149 MEA In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
  • Figure 150 MEA In Vitro Diagnostics Market Share Forecast by End-users, 2025 & 2035 (%)
  • Figure 151 GCC In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 152 South Africa In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 153 Rest of MEA In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 154 QIAGEN: Net Revenue, 2020-2024 (US$ Million, AGR %)
  • Figure 155 QIAGEN: R&D, 2020-2024 (US$ Million, AGR %)
  • Figure 156 QIAGEN: Regional Market Shares (%), 2024
  • Figure 157 QIAGEN: Business Segment Market Shares (%), 2024
  • Figure 158 BD: Net Revenue, 2020-2024 (US$ Million, AGR %)
  • Figure 159 BD: R&D, 2020-2024 (US$ Million, AGR %)
  • Figure 160 BD: Business Segment Market Shares (%), 2024
  • Figure 161 BIOMERIEUX: Net Revenue, 2020-2024 (US$ Million, AGR %)
  • Figure 162 BIOMERIEUX: R&D, 2020-2024 (US$ Million, AGR %)
  • Figure 163 BIOMERIEUX: Regional Market Shares (%), 2024
  • Figure 164 F. Hoffmann-La Roche, Ltd.: Net Revenue, 2020-2024 (US$ Million, AGR %)
  • Figure 165 F. Hoffmann-La Roche, Ltd.: R&D, 2020-2024 (US$ Million, AGR %)
  • Figure 166 F. Hoffmann-La Roche, Ltd.: Business Segment Market Shares (%), 2024
  • Figure 167 QuidelOrtho Corporation: Net Revenue, 2020-2024 (US$ Million, AGR %)
  • Figure 168 QuidelOrtho Corporation: R&D, 2020-2024 (US$ Million, AGR %)
  • Figure 169 QuidelOrtho Corporation: Regional Market Shares (%), 2024
  • Figure 170 QuidelOrtho Corporation: Business Segment Market Shares (%), 2024
  • Figure 171 Abbott: Net Revenue, 2020-2024 (US$ Million, AGR %)
  • Figure 172 Abbott: R&D, 2020-2024 (US$ Million, AGR %)
  • Figure 173 Abbott: Regional Market Shares (%), 2024
  • Figure 174 Abbott: Business Segment Market Shares (%), 2024
  • Figure 175 Agilent Technologies, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
  • Figure 176 Agilent Technologies, Inc.: R&D, 2020-2024 (US$ Million, AGR %)
  • Figure 177 Agilent Technologies, Inc.: Regional Market Shares (%), 2024
  • Figure 178 Agilent Technologies, Inc.: Business Segment Market Shares (%), 2024
  • Figure 179 Thermofisher Scientific, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
  • Figure 180 Thermofisher Scientific, Inc.: R&D, 2020-2024 (US$ Million, AGR %)
  • Figure 181 Thermofisher Scientific, Inc.: Regional Market Shares (%), 2024
  • Figure 182 Thermofisher Scientific, Inc.: Business Segment Market Shares (%), 2024
  • Figure 183 Siemens Healthineers AG: Net Revenue, 2020-2024 (US$ Million, AGR %)
  • Figure 184 Siemens Healthineers AG: Regional Market Shares (%), 2024
  • Figure 185 Siemens Healthineers AG: Business Segment Market Shares (%), 2024
  • Figure 186 Bio-Rad Laboratories, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
  • Figure 187 Bio-Rad Laboratories, Inc.: Regional Market Shares (%), 2024
  • Figure 188 Bio-Rad Laboratories, Inc.: Business Segment Market Shares (%), 2024
  • Figure 189 Danaher: Net Revenue, 2020-2024 (US$ Million, AGR %)
  • Figure 190 Danaher: R&D, 2020-2024 (US$ Million, AGR %)
  • Figure 191 Danaher: Regional Market Shares (%), 2024
  • Figure 192 Danaher: Business Segment Market Shares (%), 2024
  • Figure 193 Sysmex Corporation: Net Revenue, 2020-2024 (US$ Million, AGR %)
  • Figure 194 Sysmex Corporation: R&D, 2020-2024 (US$ Million, AGR %)
  • Figure 195 Charles River Laboratories: Net Revenue, 2020-2024 (US$ Million, AGR %)
  • Figure 196 Charles River Laboratories: Regional Market Shares (%), 2024
  • Figure 197 Charles River Laboratories: Business Segment Market Shares (%), 2024
  • Figure 198 Quest Diagnostics Incorporated: Net Revenue, 2020-2024 (US$ Million, AGR %)
  • Figure 199 Quest Diagnostics Incorporated: Business Segment Market Shares (%), 2024
  • Figure 200 Illumina, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
  • Figure 201 Illumina, Inc.: R&D, 2020-2024 (US$ Million, AGR %)
  • Figure 202 Illumina, Inc.: Regional Market Shares (%), 2024
  • Figure 203 Illumina, Inc.: Business Segment Market Shares (%), 2024
  • Figure 204 Hologic: Net Revenue, 2020-2024 (US$ Million, AGR %)
  • Figure 205 Hologic: R&D, 2020-2024 (US$ Million, AGR %)
  • Figure 206 Hologic: Regional Market Shares (%), 2024
  • Figure 207 Hologic: Business Segment Market Shares (%), 2024
  • Figure 208 Exact Sciences: Net Revenue, 2020-2024 (US$ Million, AGR %)
  • Figure 209 Exact Sciences: R&D, 2020-2024 (US$ Million, AGR %)
  • Figure 210 Exact Sciences: Regional Market Shares (%), 2024
  • Figure 211 Revvity: Net Revenue, 2020-2024 (US$ Million, AGR %)
  • Figure 212 Revvity: R&D, 2020-2024 (US$ Million, AGR %)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!